Anti-poverty groups blast Canada for accepting vaccines needed in poor countries
OTTAWA -- Two of the world's leading anti-poverty organizations are criticizing Canada's decision to draw COVID-19 vaccines from an international fund designed to help poor countries.
Oxfam Canada and the ONE Campaign say it is wrong for the federal government to agree to accept almost 1.9 million doses of vaccine from the COVAX Facility by the end of June.
Canada is one of the leading donors to COVAX, a new international partnership under the World Health Organization created last year to help deliver billions of expensive vaccine doses to poor countries that can't afford vaccinations.
In return, donor countries are allowed to receive a small percentage of vaccines for their own use, but the Trudeau Liberals have been under fire from their political opponents for doing that as Canada faces shortfalls in doses from two major international biotech firms.
Diana Sarosi, Oxfam Canada's policy director, says it is wrong for Canada to accept COVAX vaccines because of domestic political pressure and says it will ultimately do harm in poorer countries.
Stuart Hickox, the Canadian executive director of the ONE Campaign, says Canada looks bad by accepting the doses and should be making plans to share its excess vaccines.
- Almost 2.2 million more vaccine doses coming this week as COVID-19 cases spike
- Canada to get up to 1.1 m more doses by March through global vaccine alliance
- Feds pledge $440 million to join international vaccine program
- Canada mulls global vaccine contribution as Trump turns back on alliance
- Canada signs deals with Pfizer, Moderna to get doses of COVID-19 vaccines
- MISSING: 10 year old girl last seen in Mississauga
- Ten sites in Mississauga will soon allow backyard chickens
- Provinces full vaccination target may be hard to reach in Mississauga, Brampton and Ontario
- OPINION: It’s time for Doug Ford to stop deflecting and work towards reopening Brampton, Mississauga and Ontario
- One Mississauga postal code rises to 22% COVID-19 positivity rate